Liliane Fossati-Jimack Selected Research

Liliane Fossati-Jimack Research Topics

Disease

9	Glomerulonephritis 04/2016 - 10/2002
5	Inflammation (Inflammations) 01/2021 - 12/2002
4	Nephritis 08/2012 - 12/2002
3	Rheumatoid Arthritis 01/2022 - 12/2018
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2013 - 06/2003
2	Lupus Nephritis 08/2008 - 03/2006
2	Genetic Predisposition to Disease (Genetic Predisposition) 02/2008 - 02/2007
2	Anemia 06/2007 - 08/2005
1	Neoplasms (Cancer) 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Carcinogenesis 01/2021
1	Hyperplasia 01/2021
1	Necrosis 12/2020
1	Experimental Arthritis 12/2019
1	Tertiary Lymphoid Structures 12/2019
1	Infections 01/2019
1	Arthritis (Polyarthritis) 12/2018
1	Hypertriglyceridemia 09/2015
1	Dyslipidemias (Dyslipidemia) 09/2015
1	Hereditary Complement Deficiency Diseases 01/2015
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2014
1	Hyperlipidemias (Hyperlipidemia) 08/2012
1	Atherosclerosis 08/2012
1	Disease Susceptibility (Diathesis) 01/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2012
1	Cryoglobulinemia 11/2005
1	Autoimmune Diseases (Autoimmune Disease) 12/2004
1	Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis) 10/2002
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 02/2002

Drug/Important Bio-Agent (IBA)

8	Immunoglobulin G (IgG)IBA 01/2021 - 10/2002
8	AutoantibodiesIBA 12/2018 - 02/2002
4	Antigen-Antibody Complex (Immune Complex)IBA 08/2012 - 04/2004
3	Complement System Proteins (Complement)IBA 01/2021 - 11/2005
2	AntibodiesIBA 12/2018 - 02/2008
2	Immunoglobulin M (IgM)IBA 02/2008 - 06/2007
2	CryoglobulinsIBA 11/2005 - 10/2002
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Adalimumab (Humira)FDA Link 01/2021
1	Biological ProductsIBA 01/2021
1	CarcinogensIBA 01/2021
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021
1	anthraceneIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 12/2020
1	CytokinesIBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2020
1	interleukin-21 (interleukin 21)IBA 12/2020
1	Protein-Arginine DeiminasesIBA 12/2019
1	Granzymes (Granzyme)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	AntigensIBA 12/2018
1	Interleukin-27 (Interleukin 27)IBA 12/2018
1	Complement C3b (C3bi)IBA 04/2016
1	Triglycerides (Triacylglycerol)IBA 09/2015
1	Lipoproteins (Lipoprotein)IBA 09/2015
1	Pertussis ToxinIBA 09/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Interleukin-33IBA 05/2014
1	Histidine (L-Histidine)FDA Link 01/2013
1	Arginine (L-Arginine)FDA Link 01/2013
1	Fas Ligand Protein (Fas Ligand)IBA 01/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 08/2008
1	Glycoproteins (Glycoprotein)IBA 08/2008
1	Complement Receptors (Complement Receptor)IBA 06/2007
1	Immunoglobulin A (IgA)IBA 06/2007
1	Fc Receptors (Fc Receptor)IBA 06/2007
1	ElementsIBA 02/2007
1	Indicators and Reagents (Reagents)IBA 03/2006
1	DNA (Deoxyribonucleic Acid)IBA 04/2004
1	LigandsIBA 06/2003
1	Rheumatoid FactorIBA 10/2002
1	EpitopesIBA 02/2002

Therapy/Procedure

2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2012 - 12/2004
1	Biological Therapy 01/2022
1	Therapeutics 01/2021